As global tensions rise and the United States moves in a more unpredictable direction, Europe’s life science sector is under pressure to strengthen its competitiveness. According to Medicon Valley Alliance’s (MVA) CEO, Anette Steenberg, the Nordics have a decisive role to play – but only if the region can act as one.
This is one of the key take away messages in the recently published interview in Nordic Life Science News.
The role of clusters should not be underestimated, which is why the Draghi report explicitly highlighted among others Medicon Valley as one of the building block of a future Europeans life science strategy.
As you might remember, we picked up the gauntlet, reached out to some of the other European life science clusters and potential building blocks and did a deep dive into our respective strongholds and the potential for collaboration. The result was the State of Medicon Valley Report 2025, published in November last year and referred to in the article.